查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594484

神經血管設備市場：按類型、應用分類 - 2025-2030 年全球預測

Neurovascular Neurology Devices Market by Type, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年神經血管器械市場規模為30億美元，預計2024年將達32.3億美元，複合年成長率為7.79%，2030年將達50.8億美元。

神經血管設備市場包括各種旨在診斷和治療中樞神經系統（CNS）內血管疾病的技術，包括中風、動脈瘤和動靜脈畸形等疾病。由於人口老化和生活方式相關危險因子導致中樞神經系統血管疾病的盛行率不斷增加，這些設備變得至關重要。常見應用包括微創手術、栓塞、支架置入術和血栓切​​除術，主要用於需要專門神經科護理的醫院、神經科診所和門診手術中心。主要成長動力包括對神經血管疾病早期療育意識的提高，以及人工智慧整合成像系統和機器人等技術進步。在更廣泛的醫療保健和經濟成長的推動下，亞太和拉丁美洲的新興市場正在經歷不斷擴大的成長機會。利用這些機會的建議包括策略夥伴關係、對當地製造業的投資以及與不同區域衛生基礎設施一致的個人化醫療解決方案。

主要市場統計
基準年[2023] 30億美元
預測年份 [2024] 32.3億美元
預測年份 [2030] 50.8億美元
複合年成長率（%） 7.79%

儘管潛力巨大，但該市場仍面臨挑戰，包括嚴格的監管要求、與開拓先進技術相關的高成本以及缺乏接受過介入神經放射學手術培訓的熟練醫療保健專業人員。此外，發展中地區的經濟差異對先進的神經血管治療造成了財務障礙。在創新和研究方面，重點領域包括透過人工智慧和機器學習來提高設備準確性、開發生物可吸收支架以及改進非侵入性診斷技術。遠距神經病學創新還有可能擴大偏遠地區獲得優質照護的機會。該行業的特點是技術進步快、併購頻繁，注重產品的不斷改進和市場的拓展，保持活力和適度的競爭。這表明，專注於數位健康平台和基於證據的現實世界結果的公司有潛力在不斷變化的環境中定位自己，最終改善患者照護和市場成長。

市場動態：揭示快速發展的神經血管設備市場的關鍵市場洞察

供需的動態交互作用正在改變神經血管設備市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 神經系統疾病發生率增加
    • 高血壓、飲酒和吸煙的盛行率增加
    • 微創手術需求不斷成長
  • 市場限制因素
    • 缺乏熟練的神經外科醫生
  • 市場機會
    • 神經血管設備的技術進步迅速成長
    • 採用先進的血栓清除技術
  • 市場挑戰
    • 神經血管手術費用高

波特五力：駕馭神經血管設備市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解神經血管設備市場的外部影響

外部宏觀環境因素在塑造神經血管設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解神經血管設備市場的競爭格局

對神經血管設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣神經血管設備市場供應商的績效評估

FPNV定位矩陣是評估神經血管設備市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃神經血管設備市場的成功之路

神經血管設備市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 神經系統疾病發生率增加
      • 高血壓、飲酒和吸煙增加
      • 微創手術需求增加
    • 抑制因素
      • 缺乏熟練的神經外科醫生
    • 機會
      • 神經血管設備的技術進步迅速成長
      • 採用先進的血栓清除技術
    • 任務
      • 神經血管手術的手術費用高
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章神經血管設備市場：依類型

  • 頸動脈支架系統
  • 腦動脈瘤及動靜脈畸形血管內栓塞系統
  • 腦血栓清除器
  • 動脈瘤分流器
  • 顱內支架系統

第7章神經血管設備市場：依應用分類

  • 腦動脈瘤
  • 腦動脈狹窄
  • 中風

第8章美洲神經血管設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區神經血管器材市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的神經血管設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Balt USA LLC
  • Evasc Medical Systems Corp.
  • Integer Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Kaneka Corp.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Phenox GmbH
  • Rapid Medical Ltd.
  • Sensome
  • Stryker Corporation
  • Terumo Corporation
Product Code: MRR-036C5CF3B4E4

The Neurovascular Neurology Devices Market was valued at USD 3.00 billion in 2023, expected to reach USD 3.23 billion in 2024, and is projected to grow at a CAGR of 7.79%, to USD 5.08 billion by 2030.

The neurovascular neurology devices market encompasses a range of technologies designed to diagnose and treat vascular disorders within the central nervous system (CNS), including conditions such as stroke, aneurysms, and arteriovenous malformations. These devices are vital due to the increasing prevalence of CNS vascular diseases, driven by an aging population and lifestyle-related risk factors. Common applications include minimally invasive procedures, embolization, stenting, and thrombectomy, utilized primarily by hospitals, neurology clinics, and ambulatory surgical centers where specialized neurological care is required. Key growth drivers include technological advancements, such as AI-integrated imaging systems and robotics, alongside rising awareness about early intervention in neurovascular disorders. Opportunities are expanding with emerging markets in Asia-Pacific and Latin America, propelled by broader healthcare access and economic growth. Recommendations to capitalize on these opportunities include strategic partnerships, investment in local manufacturing, and personalized medical solutions catering to diverse regional health infrastructures.

KEY MARKET STATISTICS
Base Year [2023] USD 3.00 billion
Estimated Year [2024] USD 3.23 billion
Forecast Year [2030] USD 5.08 billion
CAGR (%) 7.79%

Despite its potential, the market faces challenges including stringent regulatory requirements, high costs associated with advanced technology development, and a shortage of skilled healthcare professionals trained in neurointerventional procedures. Additionally, the economic discrepancies in developing regions pose financial barriers to advanced neurovascular care. For innovation and research, focus areas include enhancing device accuracy through AI and machine learning, developing bioabsorbable stents, and improving non-invasive diagnostic techniques. Innovations in tele-neurology could also expand access to quality care in remote areas. The industry remains dynamic and moderately competitive, characterized by rapid technological advancements and frequent mergers or acquisitions, focusing on continual product enhancement and market expansion. Insight into this nature suggests that companies focusing on digital health platforms and real-world, evidence-based outcomes could position themselves strongly in the evolving landscape, ultimately leading to enhanced patient care and market growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurovascular Neurology Devices Market

The Neurovascular Neurology Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in the incidence of neurological disorders
    • Increasing prevalence of hypertension, alcohol consumption, and smoking
    • Rising demand for minimally invasive surgical procedures
  • Market Restraints
    • Lack of skilled neurosurgeons
  • Market Opportunities
    • Surge in technological advancements related to neurovascular devices
    • Adoption of advances in thrombectomy technologies
  • Market Challenges
    • High procedural cost of neurovascular surgeries

Porter's Five Forces: A Strategic Tool for Navigating the Neurovascular Neurology Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurovascular Neurology Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurovascular Neurology Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurovascular Neurology Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurovascular Neurology Devices Market

A detailed market share analysis in the Neurovascular Neurology Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurovascular Neurology Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurovascular Neurology Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neurovascular Neurology Devices Market

A strategic analysis of the Neurovascular Neurology Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Neurology Devices Market, highlighting leading vendors and their innovative profiles. These include Balt USA LLC, Evasc Medical Systems Corp., Integer Holdings Corporation, Johnson & Johnson Services, Inc., Kaneka Corp., Medtronic PLC, MicroPort Scientific Corporation, Penumbra, Inc., Phenox GmbH, Rapid Medical Ltd., Sensome, Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Neurovascular Neurology Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Carotid Artery Stenting System, Cerebral Aneurysm & AVM Endovascular Embolization Systems, Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm, and Intracranial Stent Systems.
  • Based on Application, market is studied across Cerebral Aneurysm, Cerebral Artery Stenosis, and Stroke.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the incidence of neurological disorders
      • 5.1.1.2. Increasing prevalence of hypertension, alcohol consumption, and smoking
      • 5.1.1.3. Rising demand for minimally invasive surgical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled neurosurgeons
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in technological advancements related to neurovascular devices
      • 5.1.3.2. Adoption of advances in thrombectomy technologies
    • 5.1.4. Challenges
      • 5.1.4.1. High procedural cost of neurovascular surgeries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neurovascular Neurology Devices Market, by Type

  • 6.1. Introduction
  • 6.2. Carotid Artery Stenting System
  • 6.3. Cerebral Aneurysm & AVM Endovascular Embolization Systems
  • 6.4. Cerebral Thrombectomy Devices
  • 6.5. Flow Diverter for Aneurysm
  • 6.6. Intracranial Stent Systems

7. Neurovascular Neurology Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Cerebral Aneurysm
  • 7.3. Cerebral Artery Stenosis
  • 7.4. Stroke

8. Americas Neurovascular Neurology Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Neurovascular Neurology Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Neurovascular Neurology Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Balt USA LLC
  • 2. Evasc Medical Systems Corp.
  • 3. Integer Holdings Corporation
  • 4. Johnson & Johnson Services, Inc.
  • 5. Kaneka Corp.
  • 6. Medtronic PLC
  • 7. MicroPort Scientific Corporation
  • 8. Penumbra, Inc.
  • 9. Phenox GmbH
  • 10. Rapid Medical Ltd.
  • 11. Sensome
  • 12. Stryker Corporation
  • 13. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. NEUROVASCULAR NEUROLOGY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. NEUROVASCULAR NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. NEUROVASCULAR NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEUROVASCULAR NEUROLOGY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROVASCULAR NEUROLOGY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CAROTID ARTERY STENTING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL ANEURYSM & AVM ENDOVASCULAR EMBOLIZATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL THROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTER FOR ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INTRACRANIAL STENT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL ARTERY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NEUROVASCULAR NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. NEUROVASCULAR NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023